Home / Pharma Healthcare / Global Transcatheter Heart Valves Market Research Report 2019

Global Transcatheter Heart Valves Market Research Report 2019

  • Id : RNR-264416
  • Category : Pharma Healthcare
  • Publish Date : Mar-19
  • Publisher : Research-N-Reports
  • Pages : 123
  • Format : PDF
License Type

The sales volume of transcatheter heart valves is increasing across several healthcare centers due to the growing prevalence of various heart diseases such as cardio valvular diseases, mitral regurgitation, and aortic stenosis require valve replacement. 
Increasing mortality due to chronic and end-stage cardiovascular diseases in the elderly population is a key concern for the healthcare providers across the world. As per the American Heart Association estimates in 2017, nearly 19.1 million deaths occur each year due to various cardiovascular diseases. In the U.S., heart disease is a leading cause of death, accounting for approximately 375,000 deaths per year.
Rising geriatric population is leading to a significant burden on the healthcare system. As per the UN estimates, the geriatric population in the U.S. is expected to reach over 72 million by 2022. The growth of the target population coupled with growing risk of end-stage cardiovascular diseases is expected to improve the usage of these valves. Moreover, the benefits of minimally invasive surgeries and transcatheter heart valve implantation have been strongly advocated on the basis of PARTNER I and PARTNER II clinical trials.

The global Transcatheter Heart Valves market is valued at 2330 million US$ in 2018 is expected to reach 7530 million US$ by the end of 2025, growing at a CAGR of 15.8% during 2019-2025.
This report focuses on Transcatheter Heart Valves volume and value at global level, regional level and company level. From a global perspective, this report represents overall Transcatheter Heart Valves market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Boston Scientific Corporation
ST. Jude Medical
Edwards Lifesciences Corporation
Colibri Heart Valve
On-X Life Technologies
Jenavalve Technology

Segment by Regions
North America

Segment by Type
Transcatheter Aortic Valve
Transcatheter Pulmonary Valve
Transcatheter Mitral Valve

Segment by Application